• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

SDPA Annual Summer Dermatology Conference Recap: Day 2

Article

Catch up on coverage from the second day of the 2023 SDPA Annual Summer Dermatology Conference.

Chee-Onn Leong/AdobeStock
Chee-Onn Leong/AdobeStock

Reviewing Considerations for Pigmentary Disorders With Nicole Gunasekera, MD, MBA

Nicole Gunasekera, MD, MBA, presented a session on disorders of pigmentation at the 2023 SDPA Annual Summer Dermatology Conference.

Rising Antifungal Resistance Poses a Threat to Onychomycosis Treatment

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference analyzed the growing threat of antifungal resistance, particularly with the treatment of onychomycosis in mind.

Skin Cancer in the Realm of Inflammatory Dermatoses

Darrell Rigel, MD, discusses his SDPA Annual Summer Dermatology Conference, "Inflammatory Dermatoses: A Case-Based Review," particularly highlighting the relationship between skin cancer and the inflammatory disease realm.

John Barbieri, MD, MBA, FAAD: Aligning Treatments With Patients' Experiences

John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"

Tapinarof Demonstrates Efficacy in Patient With Nonulcerated Necrobiosis Lipoidica

In the case of one patient, researchers found that topical tapinarof cream demonstrated therapeutic efficacy in nonulcerated necrobiosis lipoidica.

Renata Block, MMS, PA-C, Discusses the Role of the Dermatology PA Foundation in Supporting Physician Assistants

Renata Block, MMS, PA-C, talks about the role of physician assistants in dermatology and related organizations in supporting PAs.

Dupilumab Efficacious in Urticaria Symptom, Quality of Life Improvement

Over 24 weeks, dupilumab demonstrated efficacy in patients with chronic spontaneous urticaria.

For a full list of conference coverage from the SDPA Annual Summer Dermatology Conference, visit our conference page.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.